Low a-1 level is a significant predictor of recurrent CVD events.
The marker α-1 from the Boston Heart HDL Map test is a key player in understanding cardiovascular health. HDL, or high-density lipoprotein, often called "good cholesterol," helps carry cholesterol away from the arteries to the liver, where it can be removed from the body. Among the different types of HDL, α-1 is the most mature and efficient at clearing cholesterol from the bloodstream. When levels of α-1 HDL are low, it’s a red flag because it significantly increases the risk of recurring heart problems. Studies have shown that low α-1 HDL levels are one of the strongest predictors of future cardiovascular issues, even more so than some other well-known risk factors. This means that patients with low α-1 HDL need to be watched closely and might need to make lifestyle changes or take medications to boost their α-1 HDL levels and lower their risk of heart disease. This marker gives doctors crucial information to make better decisions about a patient's treatment and preventive care. By focusing on α-1 HDL levels, healthcare providers can more effectively manage and reduce the risk of heart attacks and other cardiovascular events in their patients.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.